139 related articles for article (PubMed ID: 10774145)
1. Myelodysplastic syndrome following treatment of malignant melanoma with vincristine, ACNU, and dacarbazine.
Kageshita T; Kuribayashi N; Ono T
J Dermatol; 2000 Mar; 27(3):178-80. PubMed ID: 10774145
[TBL] [Abstract][Full Text] [Related]
2. Therapy-related myelodysplastic syndrome developed by dacarbazine, nimustine hydrochloride and vincristine sulfate (DAV) therapy for patient with malignant melanoma.
Nitta Y; Ikeya T; Sakakibara A; Tomita Y
J Dermatol; 2011 Feb; 38(2):164-8. PubMed ID: 21269313
[TBL] [Abstract][Full Text] [Related]
3. Therapy-related myelodysplastic syndrome after alkylating agents and platinum-based therapy for malignant melanoma.
Nin-Asai R; Sawada M; Matsumoto T; Saito S; Yokota K; Akiyama M
J Dermatol; 2014 Feb; 41(2):178-9. PubMed ID: 24387309
[No Abstract] [Full Text] [Related]
4. [Chemotherapy of malignant melanoma].
Ishihara K; Yamazaki N; Asano K
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1287-92. PubMed ID: 7688498
[TBL] [Abstract][Full Text] [Related]
5. [A case report of anorectal malignant melanoma showing a complete response after DTIC/ACNU/VCR therapy].
Sasaki S; Kojima T; Hidemura A; Hatanaka K; Uekusa T; Ishimaru M
Gan To Kagaku Ryoho; 2010 Oct; 37(10):1999-2002. PubMed ID: 20948273
[TBL] [Abstract][Full Text] [Related]
6. Changes in immunological parameters after combination adjuvant therapy with intravenous DTIC, ACNU, and VCR, and local injection of IFN-beta (DAV + IFN-beta therapy) into malignant melanoma.
Umeda T; Aoki K; Yokoyama A; Ohara H; Hayashi O; Tanaka K; Nishioka K
J Dermatol; 1998 Sep; 25(9):569-72. PubMed ID: 9798342
[TBL] [Abstract][Full Text] [Related]
7. The use of DAV (DTIC, ACNU and VCR) and natural interferon-beta combination therapy in malignant melanoma.
Nagatani T; Ichiyama S; Onuma R; Miyazawa M; Matsuzaki T; Miyagawa K; Baba N; Uchiyama M; Nakajima H
Acta Derm Venereol; 1995 Nov; 75(6):494. PubMed ID: 8651034
[No Abstract] [Full Text] [Related]
8. [Control of multiple skin and lung metastasis of malignant melanoma by combined DAV and OK-432 chemoimmunotherapy in association with large-scale administration of indomethacin].
Maeda K; Miura S; Kawamura M; Jimbow K
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2434-7. PubMed ID: 6497401
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy of malignant melanoma].
Ishihara K
Gan To Kagaku Ryoho; 1995 Jan; 22(1):23-7. PubMed ID: 7529980
[TBL] [Abstract][Full Text] [Related]
10. Two cases of malignant melanoma of the toe developed skin ulcers following local injection of natural beta-interferon.
Kurashige Y; Irisawa R; Abe N; Saito M; Tsuboi R
J Dermatol; 2012 Dec; 39(12):1037-8. PubMed ID: 22758215
[No Abstract] [Full Text] [Related]
11. Complete remission of metastatic clear cell sarcoma with DAV chemotherapy.
Fujimoto M; Hiraga M; Kiyosawa T; Murakami T; Murata S; Ohtsuki M; Nakagawa H
Clin Exp Dermatol; 2003 Jan; 28(1):22-4. PubMed ID: 12558622
[TBL] [Abstract][Full Text] [Related]
12. [Acquired myelodysplastic syndromes after treatment of melanoma with fotemustine and dacarbazine].
Perrot JL; Lanthier K; Benoit F; Graille MC; Guy C; Bertheas MF; Cambazard F
Ann Dermatol Venereol; 1995; 122(10):663-6. PubMed ID: 8687048
[TBL] [Abstract][Full Text] [Related]
13. Fatal malignant melanoma in an adolescent.
Nixon RS; Geiss D; Campbell S
Pediatr Dermatol; 2010; 27(2):201-3. PubMed ID: 20537078
[TBL] [Abstract][Full Text] [Related]
14. Primary malignant melanoma of the esophagus treated by esophagectomy and systemic chemotherapy.
Matsutani T; Onda M; Miyashita M; Hagiwara N; Akiya Y; Takubo K; Yamashita K; Sasajima K
Dis Esophagus; 2001; 14(3-4):241-4. PubMed ID: 11869329
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy of malignant melanoma].
Jedrzejczak WW
Pol Arch Med Wewn; 1998 Oct; 100(4):294-9. PubMed ID: 10335037
[No Abstract] [Full Text] [Related]
16. Complete remission of metastatic malignant melanoma after surgery in association with development of systemic vitiligo.
Nishitani N; Bito T; Ikeda T; Tokura Y; Nishigori C
J Dermatol; 2010 Aug; 37(8):770-2. PubMed ID: 20649729
[No Abstract] [Full Text] [Related]
17. Dacarbazine, nimustine hydrochloride, cisplatin and tamoxifen combination chemotherapy for advanced malignant melanoma.
Yamazaki N; Yamamoto A; Wada T; Ishikawa M
J Dermatol; 1999 Aug; 26(8):489-93. PubMed ID: 10487002
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy with dacarbazine and vindesine in the treatment of metastatic malignant melanoma.
Vorobiof DA; Sarli R; Falkson G
Cancer Treat Rep; 1986 Jul; 70(7):927-8. PubMed ID: 3719588
[No Abstract] [Full Text] [Related]
19. Local injection of interferon beta in malignant melanoma of the esophagus as adjuvant of systemic pre- and postoperative DAV chemotherapy: case report with 7 years of long-term survival.
Kawada K; Kawano T; Nagai K; Nishikage T; Nakajima Y; Tokairin Y; Ogiya K; Tanaka K; Iwai T
Gastrointest Endosc; 2007 Aug; 66(2):408-10. PubMed ID: 17643724
[No Abstract] [Full Text] [Related]
20. Adjuvant chemotherapy of malignant melanoma. A pilot study.
Hansson J; Ringborg U; Lagerlöf B; Strander H
Am J Clin Oncol; 1985 Feb; 8(1):47-50. PubMed ID: 3993625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
